Abstract Purpose of Review Awareness of the molecular landscape of AML has improved
AML care over the last 5 years. This review summarizes updates regarding the diagnostic …

The list of acquired mutations with clinical value in AML is growing. Clinical implementation
of this multitude of markers will require integrated approaches and selection of markers to …

Acute myeloid leukaemia (AML) is a heterogeneous disease that is, in general, associated
with a very poor prognosis. Multiple cytogenetic and molecular abnormalities that …

Acute myeloid leukemia (AML) is a biologically complex and molecularly and clinically
heterogeneous disease, and its incidence is increasing as the population ages …

Research into the underlying pathogenic mechanisms of acute myeloid leukemia (AML) has
led to remarkable advances in our understanding of the disease. Mutations now allow us to …

Abstract Purpose of Review The field of acute myeloid leukemia (AML) has been
revolutionized in recent years by the advent of high-throughput techniques, such as next …

Acute myeloid leukemia (AML) is the most common acute leukemia diagnosed in adults, and
the majority of patients with AML die from relapsed disease. Although many studies over the …

Acute myeloid leukaemia (AML) is a disorder characterized by a clonal proliferation derived
from primitive haematopoietic stem cells or progenitor cells. Abnormal differentiation of …

Ten years ago, gene mutations found in acute myeloid leukemia (AML) were conceptually
grouped into class I mutation, which causes constitutive activation of intracellular signals that …

Molecular characterization of acute myeloid leukemia and its... : Current Opinion in Oncology
Molecular characterization of acute myeloid leukemia and its impact on treatment : Current …